ISOPP Standards for the Safe Handling of Cytotoxics

by | Aug 31, 2022 | What’s new on CytoPrevent | 0 comments

ISOPP Standards for the Safe Handling of Cytotoxics

 

Since the initial release of the International Society of Oncology Pharmacy Practitioners (ISOPP) Standards for the Safe Handling of Cytotoxic Drugs in 2007, much has evolved in oncology pharmacy. Safe handling practices have been refined and new hazardous agents have been discovered and developed for treatment to pose new challenges for workers caring for their patients.

As ISOPP continues to serve as a global leader to promote safe handling of hazardous agents, the ISOPP Standards task force was appointed by the society to undertake a comprehensive and evidence-based review of 21 old standards and added eight new standards to focus on additional areas of practice.

With the help of many members from across the world, the ISOPP Standards of Practice have been updated for the current state of practice in oncology pharmacy.

The following ISOPP members have contributed to one or more of the new standards:

Marliese Alexander, Australia
Thomas H. Connor, USA
Tiene Bauters, Belgium
Marissa C. Alexander, USA
Barbara A. MacKenzie, USA,
Johan Vandenbroucke, Belgium
Harbans Dhillon, Malaysia
Sylvie Crauste-Manciet, France
Carole Chambers, Canada
Mayde Torriani, Brazil
Robbie McLauchlan, Australia
Lisha Ng, Malaysia
Asunción Albert Marí, Spain
Carien van der Merwe, South Africa
Steve Stricker, USA
Evelyn Handel, USA
Wael Abi Ghanem, Lebanon
Rowena (Moe) Schwartz, USA
Shinya Suzuki, Japan
Graham Sewell, England
Racha Sabbagh Dit Hawasli, Lebanon
Shereen Nabhani-Gebara, England
Paul Sessink, Sweden
Sandrine von Grünigen, Switzerland

The following members have contributed to one or more of the reviewed standards:

Shaun O’Connor, Australia
Alexandre Chan, USA
Kimberley-Ann Kerr, Australia
Harbans Dhillon, Malaysia
Racha Sabbagh Dit Hawasli, Lebanon
Lauren Hutton, Canada
Paul Sessink, Sweden
Sylvie Crauste-Manciet, France
Thomas H. Connor, USA
Michelle Koberinski, Canada
Peter Yap, Singapore
Lynne Nakashima, Canada
Gozde Yesilyaprak, Turkey
Sarah Lo, Taiwan
Michael Moloney, Australia
Antoine Sedrak, Australia
Sandra Palacios, Chile
Sarah Glewis, Australia
Julie Kan, Australia
Suzanne Staude, Australia
Gouri Shankar Bhattacharyya, India
Alison Palumbo, USA
Habibah Binti Kamaruzaman, Malaysia
Emma Foreman, England
Suhaime Ali, Malaysia

Finally, the committee who helped with reviewing membership feedback:

Tiene Bauters, Belgium
Shereen Nabhani-Gebara, England
Harbans Dhillon, Malaysia
Carien van der Merwe, South Africa
Emma Foreman, England
Alison Palumbo, USA
Racha Sabbagh Dit Hawasli, Lebanon
Lynne Nakashima, Canada

As can be clearly seen, the work of updating and releasing these new standards has been contributed to by many of the members of ISOPP, and we must thank them for their willingness to contribute their
knowledge.

These Standards of Practice will continue to be used as an advocacy tool for pharmacists around the world in improving cytotoxic safe handling and care for patients.

Shaun O’Connor (Australia)
Kimberley-Ann Kerr (Australia)
Alexandre Chan (USA)
ISOPP Standards Committee Co-Chairs

 

To read the full paper, click here.

 

Source: Journal of Oncology Pharmacy Practice – 2022, Vol. 28 3(Supplement) 1–126

0 Comments

Leave a Reply